Glaucoma Care in Gurgaon

Dr Shibal Bhartiya provides glaucoma care in Gurgaon, focusing on early detection, risk stratification, and long-term management of glaucoma to prevent irreversible vision loss. Care typically includes detailed optic nerve evaluation, OCT and visual fields, and personalised treatment plans tailored to disease stage and progression risk.

Early detection. Risk-based care. Long-term vision protection. Glaucoma often develops silently, but the risk can be identified early with the right tests and careful interpretation, before vision loss becomes irreversible. Dr Shibal Bhartiya, fellowship-trained glaucoma specialist in Gurgaon, brings together evidence-based insights on screening, risk stratification, and long-term care to help protect vision over time.

Glaucoma is a silent, progressive disease. Vision loss often occurs gradually and cannot be reversed. The goal of care is not just lowering eye pressure, but protecting the optic nerve safely over time.

If you are looking for a glaucoma specialist in Gurgaon, treatment decisions should be based on risk, progression, and long-term safety, not just the number of medications.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.


🧠 A Different Approach to Glaucoma Care

Glaucoma is often managed reactively, pressure rises, more drops are added. But glaucoma is a long-arc disease.

Effective care focuses on:

This is not about doing more. It is about doing what is right, at the right time.


🔎 Start Here: Understanding Your Glaucoma

If you are trying to understand your diagnosis or treatment, these guides will help:


⚠️ When Should You Be Concerned?

You should consider evaluation if you have:

  • Family history of glaucoma
  • Increasing number of eye drops
  • Redness, irritation, or intolerance to medications
  • “Normal” eye pressure but worsening reports
  • Difficulty understanding your treatment plan

Glaucoma often progresses silently. Waiting for symptoms can delay care.

If this sounds familiar, it may be time to consider a glaucoma second opinion:
https://drshibalbhartiya.com/glaucoma-second-opinion-gurgaon/


🧪 How Glaucoma Is Evaluated

Accurate glaucoma care requires more than a pressure check.

Assessment includes:

Understanding glaucoma progression through OCT and visual field analysis is key to making safe treatment decisions.


💊 Treatment Is Not Just About Eye Drops

Treatment options may include:

Adding more medications is not always the safest approach.
In many cases, treatment strategy matters more than the number of drops used:
https://drshibalbhartiya.com/more-glaucoma-eye-drops-not-better-care/

Target IOP

Managing side effects of glaucoma drops


🔁 Long-Term Care Matters

Glaucoma requires:

  • Regular follow-up
  • Consistent monitoring
  • Adjustment based on progression

The goal is:

  • Stable vision
  • Minimal side effects
  • Sustainable treatment

👁️ Not Sure Where You Stand?

If:

  • you are on multiple eye drops
  • your reports are difficult to interpret
  • or your condition seems to be progressing

A structured evaluation can help simplify your treatment.

👉 Request a glaucoma second opinion:
https://drshibalbhartiya.com/glaucoma-second-opinion-gurgaon/

Clinical Reality (What’s not always obvious)

  • Good glaucoma care is not a one-time consultation—it’s longitudinal monitoring of glaucoma over years.
  • A “normal” eye pressure does not guarantee safety—progression can occur despite seemingly controlled numbers.
  • Technology (OCT, visual fields) supports care, but clinical judgement and pattern recognition over time are what prevent vision loss.
  • Over-treatment (too many drops) and under-treatment (delayed escalation) are both risks—balance is key.
  • The quality of follow-up and consistency of care often matter more than any single test or visit.

What you Must Remember

AspectWhat It Means for You
Core goalPreserve vision long-term by slowing disease progression
Key evaluationsOptic nerve exam, OCT, visual fields, eye pressure
Treatment optionsEye drops, laser (SLT), surgery if needed
Follow-up importanceRegular monitoring detects early progression
PersonalisationCare tailored to risk, lifestyle, and response
When to seek specialist careUncertain diagnosis, progression, second opinion
Role of technologySupports early detection and tracking
Systemic factorsSleep, blood pressure, health influence outcomes
Patient roleAdherence to treatment and follow-up is critical
Big pictureGlaucoma care is ongoing risk management, not a one-time fix

FAQs About Glaucoma Care in Gurgaon

When should I see a glaucoma specialist in Gurgaon?

You should see a glaucoma specialist if you have a family history of glaucoma, are on an increasing number of eye drops, experience redness or irritation from your medications, have been told your eye pressure is normal but your reports are worsening, or find your current treatment plan difficult to understand. Glaucoma often progresses silently. Waiting for symptoms can delay care and lead to irreversible vision loss.


What tests are done in a glaucoma evaluation?

A comprehensive glaucoma evaluation includes optic nerve examination, OCT imaging of the optic nerve and retinal nerve fibre layer, visual field testing, corneal thickness measurement, and risk profiling over time. A pressure check alone is not sufficient to evaluate or manage glaucoma safely. Each of these tests contributes a different piece of information about disease risk and progression.


What is a glaucoma second opinion and when is it needed?

A glaucoma second opinion is a structured, independent review of your diagnosis and treatment plan. It is useful when you are on multiple eye drops, when your condition seems to be progressing despite treatment, when reports are difficult to interpret, or when your treatment plan feels unclear. Dr Shibal Bhartiya offers dedicated glaucoma second opinion consultations in Gurgaon, with a focus on simplifying decisions and protecting vision long-term.


Is adding more eye drops always the right treatment for glaucoma?

No. Adding more medications is not always the safest or most effective approach. Glaucoma treatment should be based on risk, rate of progression, side effect burden, and long-term safety. In many cases, treatment strategy matters more than the number of drops prescribed. Laser procedures or surgical options may be more appropriate than escalating medications, depending on the individual case.

About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine. This article was updated in April 2026.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

Access her work on PubmedGoogle ScholarResearchGate and ORCID.

Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care

www.drshibalbhartiya.com
 +91 88826 38735

1500+ Five Star Patient Reviews Google Business Profile

Upload your reports for a structured review.

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma

Related Reading

Get an Online Glaucoma Consult

Why Do I Need a Visual Field Test?

Understanding Your OCT Report in Glaucoma

Visual Field and OCT: Structure & Function Correlation

Gonioscopy

Glaucoma Diagnosis in Gurgaon

Glaucoma Progression: What It Means and How to Slow It

Glaucoma treatment in Gurgaon

All About Glaucoma Medication

Glaucoma Lasers: SLT & LPI

Glaucoma surgery in Gurgaon

MIGS in Gurgaon

Get a Glaucoma Second Opinion in Gurgaon

Risk Stratification in Glaucoma

Most glaucoma decisions are not about what your reports show today. They are about what your eyes are likely to…

5 Mistakes Patients Make in Glaucoma Care

The five most common mistakes glaucoma patients make are: stopping eye drops when vision feels stable, missing follow-up appointments, ignoring family risk, self-managing side effects without telling their doctor, and assuming normal eye pressure means they are safe. Each mistake can silently accelerate nerve damage before any symptom appears, explains Dr Shibal Bhartiya.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.

Glaucoma is called the silent thief of sight for a reason. Most patients feel nothing until the damage is severe. That silence is exactly what makes certain habits so dangerous. These five mistakes are not careless choices. They are logical responses to a disease that gives no pain, no blur, and no warning. Understanding why each mistake happens is the first step to avoiding it.


5 Mistakes Glaucoma Patients Commonly Make

Mistake 1: Stopping Eye Drops When Vision Feels Fine

What patients do: They use drops for a few weeks, vision feels unchanged, and the drops get quietly abandoned. Life gets busy. The bottle runs out. It feels pointless to medicate something that causes no symptoms.

Why this is dangerous: Glaucoma drops do not improve vision. They protect the optic nerve from further damage. Stopping them does not feel like anything in the short term. But intraocular pressure rises within days of missing doses, and nerve damage accumulates silently over months.

What doctors often miss saying: Patients are rarely told that the goal of treatment is preservation, not improvement. When that is not explained clearly, stopping drops feels like a rational choice.

Real-world picture: Studies show that over 50% of glaucoma patients have poor drop adherence within one year of diagnosis. Many do not tell their doctor. Pressure readings at clinic visits look normal because patients resume drops a few days before their appointment.


Mistake 2: Skipping Follow-Up Appointments

What patients do: They feel well, work is busy, travel is expensive, and the appointment gets pushed by a month, then three months, then indefinitely.

Why this is dangerous: Glaucoma progression is invisible to the patient. Visual field loss in early and moderate glaucoma occurs in the peripheral vision first. Patients do not notice it in daily life. Only structured testing at follow-up reveals whether the nerve is stable or declining.

What doctors often miss saying: The frequency of follow-up is not arbitrary. It is calibrated to the rate of progression risk. Missing two visits in a year can mean missing a window to escalate treatment before irreversible loss occurs.

Real-world picture: A patient who feels fine and delays follow-up for six months may arrive to find their visual field has worsened by a measurable step. That step cannot be reversed.


Mistake 3: Ignoring Family History as a Personal Risk Signal

What patients do: A parent or sibling has glaucoma. The patient assumes they will know if they develop it too. They wait for symptoms before seeking screening.

Why this is dangerous: A first-degree family history of glaucoma increases personal risk by four to nine times. Glaucoma runs in families and often presents a decade earlier in the next generation. Waiting for symptoms means waiting until 30 to 40 percent of nerve fibres are already gone.

What doctors often miss saying: Screening is not just for people who already have symptoms. It is most valuable precisely when there are no symptoms yet.

Real-world picture: Many patients present to a glaucoma clinic only after a family member goes blind. By that point their own disease is already moderate or advanced.


Mistake 4: Managing Side Effects Silently Instead of Telling the Doctor

What patients do: Eye drops cause redness, stinging, darkened lashes, or a persistent dry eye feeling. Patients tolerate it quietly or stop the drops without informing anyone. They assume this is just how glaucoma treatment feels.

Why this is dangerous: Side effects are one of the most common reasons for treatment failure. Patients who stop drops due to side effects but do not report it appear adherent on their records. Pressure goes uncontrolled. The doctor has no reason to switch the formulation or try a preservative-free option.

What doctors often miss saying: There are multiple drop classes, combination formulations, and preservative-free alternatives. No patient needs to tolerate a drop that makes their eyes miserable. Laser treatment is also a first-line option that removes the drop burden entirely for many patients.

Real-world picture: A switch from a preserved to a preservative-free prostaglandin analogue resolves surface irritation in most patients within four to six weeks. Many patients never knew this option existed.


Mistake 5: Believing Normal Eye Pressure Means No Glaucoma Risk

What patients do: They have an eye check, are told pressure is normal, and conclude they do not have glaucoma and never will.

Why this is dangerous: Normal tension glaucoma is a well-documented condition in which nerve damage progresses despite intraocular pressure within the statistically normal range. In South Asian and East Asian populations this pattern is particularly common. Additionally, what is normal for the population may not be safe for a specific individual nerve.

What doctors often miss saying: Glaucoma diagnosis requires examination of the optic nerve, retinal nerve fibre layer imaging, and visual field testing. Pressure alone does not rule it out.

Real-world picture: Normal tension glaucoma accounts for a significant proportion of glaucoma in India. Patients with a normal pressure reading and a cupped nerve need full evaluation, not reassurance.


What This Table Shows You

MistakeWhat Patients BelieveThe Clinical Reality
Stopping dropsVision is stable so drops are not neededDrops preserve nerve, not vision
Missing follow-upNo symptoms means no progressionProgression is invisible without testing
Ignoring family historySymptoms will warn them in timeRisk is high and silent from the start
Tolerating side effectsThis is how treatment always feelsAlternatives exist; tell your doctor
Trusting normal pressureNormal IOP means no glaucomaNormal tension glaucoma is common in India

When to Worry

Seek an urgent glaucoma review if you notice any of the following. Sudden eye pain or headache with blurred vision and halos around lights. A family member has been recently diagnosed with glaucoma. Your vision seems to have narrowed or you are missing objects at the side. You have been using drops irregularly for more than one month. You have not had an optic nerve assessment in over a year.


What This Means for You

Glaucoma is manageable. Most patients who lose vision do so not because treatment failed but because the disease was caught late, treatment was abandoned, or follow-up was missed. None of these are irreversible situations if caught in time. The single most protective thing you can do is stay engaged with your care even when everything feels normal.


Frequently Asked Questions

Can glaucoma get worse even if I use my drops every day?

Yes. Drops reduce intraocular pressure but progression can continue in some patients despite good pressure control. This is why regular follow-up and nerve imaging remain essential even with perfect adherence.

How often should a glaucoma patient see their doctor?

Most stable patients need review every three to six months. Patients with active progression or recent treatment changes may need monthly visits. Your doctor will set the schedule based on your specific risk.

Is glaucoma hereditary and should my children be tested?

Yes, glaucoma has a strong hereditary component. First-degree relatives of a glaucoma patient should have a full eye examination including optic nerve assessment from the age of 35, or earlier if they have other risk factors.

What should I do if my eye drops are causing side effects?

Tell your doctor at the next visit and do not stop drops without guidance. There are multiple formulations, preservative-free options, and laser alternatives that may suit you better. Side effects are a solvable problem.

Does normal eye pressure rule out glaucoma?

No. Normal tension glaucoma is well recognised and common in Indian patients. A complete glaucoma evaluation includes optic nerve examination and imaging, not pressure measurement alone.


Speak to a Glaucoma Specialist

If you have been diagnosed with glaucoma and are unsure whether your treatment is working, or if you have a family history and have never had a full nerve assessment, a second opinion is always appropriate. Early course correction protects what cannot be recovered.

📍 Dr Shibal Bhartiya — Marengo Asia Hospitals, Gurugram

📞 +91 88826 38735 | 🌐 www.drshibalbhartiya.com


About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

Access her work on PubmedGoogle ScholarResearchGate and ORCID.

Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care

www.drshibalbhartiya.com
 +91 88826 38735

1500+ Five Star Patient Reviews Google Business Profile

Upload your reports for a structured review.

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma

Related Reading

Get an Online Glaucoma Consult

Visual Field and OCT: Structure & Function Correlation

Glaucoma Diagnosis in Gurgaon

Risk Stratification in Glaucoma

Glaucoma Progression: What It Means and How to Slow It

Glaucoma treatment in Gurgaon

All About Glaucoma Medication

Glaucoma Lasers: SLT & LPI

Glaucoma surgery in Gurgaon

MIGS in Gurgaon

Get a Glaucoma Second Opinion in Gurgaon

Eye Health After 60

After 60, your eyes face a different set of risks than they did at 40. Glaucoma, macular changes, cataract progression, and dry eye all accelerate in this decade. Many of these conditions cause no pain and no obvious warning. Which is why regular, detailed eye evaluation is essential after 60, not optional, explains Dr Shibal Bhartiya.

Most people over 60 assume that blurred vision means they need new glasses. Sometimes that is true. But in this age group, vision changes are often the first sign of something that needs treatment, not just a new prescription. The good news is that caught early, most serious eye conditions in this decade are manageable. The risk is waiting too long.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.


7 Eye Conditions That Are More Common After 60

  1. Glaucoma
  2. Age-related macular degeneration (AMD)
  3. Cataract
  4. Diabetic retinopathy
  5. Dry eye disease
  6. Posterior vitreous detachment (PVD)
  7. Eyelid and tear duct changes

What Each Condition Means for You

1. Glaucoma

Glaucoma damages the optic nerve, usually without pain or early vision loss. After 60, the risk rises sharply. Most people with glaucoma do not know they have it until significant damage has occurred. A detailed evaluation includes eye pressure, optic nerve imaging, and visual field testing; not just a standard check.

2. Age-Related Macular Degeneration (AMD)

AMD affects the centre of your vision, the part you use for reading, faces, and fine detail. Early AMD causes no symptoms. Intermediate AMD may cause slight blurring or difficulty in low light. Wet AMD can cause rapid central vision loss. Early detection through retinal imaging changes outcomes significantly.

3. Cataract

Most people over 60 have some degree of cataract. Symptoms include glare, halos at night, faded colours, and gradual blurring. Cataract surgery is one of the safest and most effective procedures available. The decision to operate depends on how much the cataract affects daily function, not just its appearance on examination.

4. Diabetic Retinopathy

If you have diabetes, your retinal risk increases significantly with age. Diabetic retinopathy can progress silently for years. Blood sugar control slows progression, but it does not eliminate the need for annual retinal evaluation. Even well-controlled diabetes requires regular retinal screening.

5. Dry Eye Disease

Tear production decreases with age, particularly after menopause in women. Symptoms include burning, grittiness, watery eyes, and fluctuating vision. Standard Schirmer tests often miss functional dry eye. A detailed tear film assessment gives a more accurate picture. Untreated dry eye accelerates surface damage and worsens visual quality.

6. Posterior Vitreous Detachment (PVD)

The vitreous gel inside the eye shrinks and pulls away from the retina with age. This causes sudden floaters and flashes of light. PVD itself is usually harmless. However, in some cases it causes a retinal tear, which needs urgent treatment. New floaters or flashes after 60 always need same-week evaluation.

7. Eyelid and Tear Duct Changes

Eyelids lose tone with age. They may turn inward (entropion) or outward (ectropion), both causing irritation and tearing. Blocked tear ducts also become more common. These are correctable conditions, but they are frequently dismissed as “just aging.”


How to Think About Your Symptoms After 60

SymptomPossible CauseWhen to Worry
Gradual blurringCataract, refractive changeWorsening over weeks
Peripheral vision lossGlaucomaAny unexplained gap in vision
Central blurring or distortionAMDSudden or rapid change — urgent
Flashes and new floatersPVD, retinal tearNew onset — same week evaluation
Burning, gritty eyesDry eye, eyelid changesPersistent or worsening
Night driving difficultyCataract, contrast loss, glaucomaFunctional impairment
Watery eyesBlocked tear duct, ectropionChronic and affecting vision

Eye Health After 60: What to Expect

Your eyes change significantly after 60. Most of these changes are normal, but some need early attention to protect your vision.

After 60, the eye’s lens becomes stiffer and cloudier. The drainage system slows down. The retina becomes more vulnerable. None of this is unusual. All of it is manageable when caught early.

What Normally Changes After 60

Reading vision gets harder. The lens loses flexibility. This is called presbyopia. You may need reading glasses even if your distance vision is fine. This is not a disease. It is a normal part of ageing.

Contrast sensitivity drops. You may find it harder to read in low light or see steps clearly. Colours may look less vivid. This happens because the pupil becomes smaller and lets in less light.

Floaters increase. Most floaters are harmless. They are shadows from tiny fibres in the vitreous gel inside your eye. But a sudden shower of new floaters, especially with flashing lights, needs urgent attention. It can signal a retinal tear.

Dry eyes become more common. The glands that produce tears work less efficiently with age. Eyes feel gritty, tired, or burning. Dry eye is one of the most common eye complaints after 60 and is very treatable. [internal link: /omega-3-dry-eye/]

Adaptation to dark and light slows. Moving from bright sunlight into a dim room takes longer. This is normal but can affect driving safety at night.What Routine Tests Often Miss

Remember

Many eye evaluations in this age group focus on correcting the glasses prescription and checking eye pressure. That misses the full picture. Contrast sensitivity, tear film quality, optic nerve structure, and macular health all need individual assessment. A normal eye pressure does not rule out glaucoma. Clear-looking eyes do not rule out AMD or early retinal changes. After 60, a complete evaluation takes longer than ten minutes.


When to Worry

See an eye specialist promptly if you notice any of the following:

  • Sudden new floaters or flashes of light
  • Any sudden change in central vision
  • A shadow or curtain across part of your vision
  • Rapid worsening of night vision
  • Vision loss that does not improve with blinking
  • Double vision in one or both eyes

Annual evaluation is the minimum after 60. Six-monthly evaluation is appropriate if you have glaucoma, diabetes, or AMD.


What This Means for You

Ageing affects every part of the body, and the eyes are no exception. But most serious eye conditions after 60 are treatable when found early. The goal of eye care in this decade is not just clearer glasses, it is protecting the vision you have for the decades ahead. If your last eye check was more than a year ago, now is the right time.

How Often Should You Have Your Eyes Examined After 60?

Once a year, without exception.

A comprehensive annual eye exam after 60 checks vision, eye pressure, the optic nerve, the retina, and the drainage angle. It takes less than an hour. It can detect cataracts, glaucoma, macular degeneration, and diabetic eye disease before you notice any change in your vision.

If you have diabetes, hypertension, a family history of glaucoma, or previous eye conditions, your eye doctor may recommend more frequent reviews.


What a Comprehensive Eye Exam Includes

  • Vision testing at distance and near
  • Eye pressure measurement
  • Optic nerve assessment
  • Dilated retinal examination
  • Corneal thickness if glaucoma risk is present
  • Visual field testing if indicated [internal link: /visual-field-test/]
  • OCT scan of the optic nerve and retina if needed [internal link: /rnfl-oct/]

Practical Steps to Protect Your Eyes After 60

Wear UV-protective sunglasses outdoors. UV exposure accelerates cataracts and macular degeneration. A good pair of wrap-around sunglasses is one of the simplest protective steps you can take.

Manage your systemic health. Blood pressure, blood sugar, and cholesterol directly affect your eyes. Keeping these controlled reduces your risk of retinal vascular disease and diabetic eye disease.

Eat well. A diet rich in leafy greens, colourful vegetables, and omega-3 fatty acids supports retinal health. [internal link: /omega-3-dry-eye/]

Do not smoke. Smoking doubles the risk of macular degeneration and accelerates cataract formation. It is the single most modifiable risk factor for serious eye disease.

Tell your eye doctor about all medications. Some systemic drugs affect the eyes. Hydroxychloroquine, used for rheumatoid arthritis and lupus, requires annual retinal monitoring. Certain blood pressure medications affect eye pressure.


A Note on Second Opinions

If you have been told you have early cataracts, early glaucoma, or macular changes and you are unsure about next steps, a second opinion is always appropriate. Understanding exactly what stage you are at and what your options are makes a meaningful difference to long-term outcomes.


Frequently Asked Questions

Is it normal for vision to change a lot after 60?

Some change is normal. But frequent or rapid changes need evaluation. They may indicate cataract progression, dry eye, or an early retinal or nerve problem.

Can glaucoma start after 60 even with no family history?

Yes. Age itself is a major risk factor for glaucoma. Family history adds to the risk but is not required for the disease to develop.

I had cataract surgery. Do I still need regular eye checks?

Yes. Cataract surgery removes the cloudy lens but does not protect against glaucoma, AMD, retinal changes, or dry eye. Annual evaluation remains important.

How is eye care after 60 different from a standard vision test?

A standard vision test checks your glasses prescription and basic eye pressure. A complete evaluation after 60 includes optic nerve imaging, visual field testing, retinal assessment, and tear film evaluation. These are different tests with different equipment.

Can AMD be prevented?

Early AMD cannot always be prevented, but progression can be slowed. Stopping smoking, controlling blood pressure, and taking specific nutritional supplements in intermediate AMD are evidence-based steps. Early detection through retinal imaging is essential.


See a Specialist Who Looks Beyond the Obvious

After 60, eye care is not just about reading the chart. It is about protecting your independence, your ability to drive, and your quality of life. If something feels off, or if it has been more than a year since a detailed evaluation, book a consultation.

Dr Shibal Bhartiya Glaucoma and Advanced Eye Care | Second Opinions

🌐 www.drshibalbhartiya.com 📞 +91 88826 38735



About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

Access her work on PubmedGoogle ScholarResearchGate and ORCID.

Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care

www.drshibalbhartiya.com
 +91 88826 38735

1500+ Five Star Patient Reviews Google Business Profile

Upload your reports for a structured review.

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma

Do You Really Need Treatment for Glaucoma?

Glaucoma treatment is not always immediate or automatic. The glaucoma treatment decision depends on confirmed diagnosis, risk of progression, and long-term impact, not a single test result. Most people who come to me with a glaucoma diagnosis are not asking for treatment. They are asking something much more basic: Do I really need to start treatment for glaucoma?”

And often, that question has not been fully answered. Here’s what you need to make your glaucoma treatment decision, explains Dr Bhartiya.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.


The uncomfortable truth

Not all glaucoma needs immediate treatment. Not all treatment prevents progression. And not all progression is fast enough to matter in the short term.

But equally: Some patients lose vision quietly while everything appears “stable.”

👉 The difficulty is not diagnosis.
👉 The difficulty is decision-making over time.


What actually determines treatment

Treatment is not based on one number or one test.

It depends on:

  • Your age and life horizon
  • The structure of your optic nerve
  • Functional change over time (not one field test)
  • Risk of progression, not just presence of disease

This is where most consultations become oversimplified.


When you should pause before starting treatment

  • You’ve had one abnormal test only
  • Your scans and fields don’t match
  • You have no clear baseline
  • The diagnosis was made quickly without longitudinal review

In these cases, a second opinion is not delay, it is risk correction.


When treatment should not be delayed

  • Clear structural damage with progression risk
  • Repeatable field defects
  • Strong family history with early signs
  • Younger patients with long disease horizon

Here, waiting creates silent loss.


Understanding Glaucoma

Glaucoma is not a yes/no diagnosis. It is a long-arc risk management problem.

The real question is not: “Do I have glaucoma?”

But: “What happens if we do nothing for the next 5–10 years?”

👉 If that question has not been answered clearly, you are not ready to commit to treatment yet.

Known for her structured approach to glaucoma risk assessment and progression analysis, Dr Shibal Bhartiya provides trusted second opinions for patients seeking clarity before major treatment decisions. Both, in person, and online.

If you’ve been advised treatment but are unsure whether it’s necessary, a structured second opinion can help clarify both diagnosis and long-term risk. Second Opinion Form

❓ FAQs

Do all glaucoma patients need treatment?

No. Some patients need careful observation before starting treatment. The key is assessing risk of progression over time, not just presence of early changes.


Can I wait before starting glaucoma drops?

In selected cases, yes, but only with structured monitoring. Waiting without a plan is risky. Waiting with clear follow-up and baseline comparison can be appropriate.


Are glaucoma eye drops lifelong?

Often, yes. That’s why the decision to start should be made carefully. Starting treatment is easy. Continuing it for years is what affects quality of life.


What happens if I delay treatment?

It depends on your individual risk. Some patients remain stable for years. Others may progress silently. The decision should be based on:

  • age
  • baseline damage
  • rate of change

And not fear alone.


Can glaucoma be treated without drops?

In some cases, laser or surgery may be options. But the real question is not the method, it is whether treatment is needed at all, and when.


Why do different doctors give different opinions?

Because glaucoma is not a binary diagnosis.
It involves interpretation of:

  • tests
  • patterns
  • risk over time

Different doctors may weigh these differently, especially without long-term data.


When should I seek a second opinion?

  • Diagnosis made on limited testing
  • Conflicting reports
  • Uncertainty about starting lifelong treatment
  • Progression despite treatment

Read the research articles

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

Access her work on PubmedGoogle ScholarResearchGate and ORCID.

Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care

www.drshibalbhartiya.com
 +91 88826 38735

1500+ Five Star Patient Reviews Google Business Profile

Upload your reports for a structured review.

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma

Related Reading

Get an Online Glaucoma Consult

Visual Field and OCT: Structure & Function Correlation

Glaucoma Diagnosis in Gurgaon

Risk Stratification in Glaucoma

Glaucoma Progression: What It Means and How to Slow It

Glaucoma treatment in Gurgaon

All About Glaucoma Medication

Glaucoma Lasers: SLT & LPI

Glaucoma surgery in Gurgaon

MIGS in Gurgaon

Get a Glaucoma Second Opinion in Gurgaon